DEXWireNews

DEXWireNews

The speculation regarding a possible buyout has gathered steam, but we are of the opinion that the $9 price is lower than what the company is actually worth. The stock has a very high short interest of 21% which has helped drive down the price from $16 a year earlier. Just 2 Hedge funds are in control of 30% of the shares with 1 of those funds Armatice, having...

DEXWireNews

*****WE KEEP ALERTS SET ON THIS NAME AND BUY ORDER IN PLACE, RUMOR HAS IT THERE IS A MOVE COMING SOON, WITH MASSIVE UPSIDE POTENTIAL****** James mc Carthy from MAxim recently maintained his buy rating and initiated a $3 price target citing. “Biocept reported 1Q19 with ~$1M in revenue and a net loss of $5.9M. The company ended the period with $14.8M in cash on the...

DEXWireNews

Agile Therapeutics has resubmitted its U.S. marketing application for contraceptive patch Twirla, this follows the company receiving a CRL in December 2017 citing the need for additional adhesion data. Keep this on the watch-list for today and they weeks to come. When this moves it will be fast and frantic. Analyst Rating Overweight. 3 Buy 2 Hold Agile...

DEXWireNews

This was a real winner yesterday and today is going to be the same, already up 12% pre market, we think there should be continuation in this name for days to come. Outlook Therapeutics started at outperform with $12 stock price target at Oppenheimer OUTLOOK THERAPEUTICS INC. Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm...

DEXWireNews

Experts and analysts are falling over one another to upgrade GBT so it is no surprise it has had a beautiful run in 2019. Don't worry if you have missed out this is just the start, as commercialization becomes a reality. The company's under-the-radar licensing of inclacumab "completes the package", making Global Blood Therapeutics a force to reckon with in sickle...

DEXWireNews

We expect a sizable move in Scorpio Tankers in the coming days , analysts were already bullish on the stock and it has once again received a upgrade from JP Morgan to overweight with a $34 price target today. They shipping stocks have been in a bear market for many years but that has now changed. The chart of STNG has formed a lovely base and is now set to...

DEXWireNews

Xoma corp has just received some glowing recommendations, one of which is from H.C Wainwright analyst Joseph Pantginis who has a buy rating with a $30 price target. He wrote, "We reiterate our Buy rating and $30 target. We highlight that we currently omit the 38 undisclosed partnered assets at the company, and look to provide potential contribution once...

DEXWireNews

****UPDATE**** THIS WILL RUN HARD TODAY, MASSIVE POTENTIAL ON RUMOR OF NON BINDING AGREEMENT WITH POTENTIAL BUYER.

DEXWireNews

Container Store reported fourth-quarter profit of $15.88 million, or 33 cents a share, from a loss of $399,000, or a penny a share, a year earlier. Revenue rose 8.8% to $253.2 million while comparable store-sales gained 8.5%. Analysts surveyed by FactSet had forecast earnings of 30 cents a share on revenue of $243 million. Expect some analysts upgrades to follow...

DEXWireNews

HCHC HAS A FANTASTIC EARNINGS REPORT, CUTTING LOSES DRASTICALLY AND INCREASING REVENUES. THIS STOCK IS EXTREMELY UNDERVALUED AND WE BELIEVE A BREAKOUT IS POSSIBLE IN THE COMING DAYS WHEN THE MARKET BECOMES MORE STABLE. Company Description HC2 Holdings, Inc. engages in the acquisition and investment activities. It operates through following business segments:...

DEXWireNews

***********If today's market was not such a disastrous sell zone NXTD could have had a nice rally, keep it on your alert list for a significant breakout in the coming days*************** Company Description Nxt-ID, Inc. is a technology company, which engages in the development of hardware and software security systems and applications. The company focuses on the...

DEXWireNews

Ocean Power Technology is having a incredible day after its announcement on the success of POWERBOY. Had the market not been in such turmoil today it surely could have rallied a lot harder. PowerBuoy deployed in the Adriatic Sea has produced more than one MegaWatt-hour cumulative energy to date, Company Description Ocean Power Technologies, Inc. is a renewable...

DEXWireNews

MARA surprised the market today with a blow out quarter, cutting it's operating loss in half to $988,000 and posting a loss per share of $.16 cpmpared to $.64 in 2018. Merrick Okamoto, Chief Executive Officer, stated, “We’re pleased to show significant financial improvement on a year over year basis including significant reductions in our operating costs, While...

DEXWireNews

TBLT is a specialist tool maker for the DIY sector. ACCESSWIRE reports " TBLT announced that its U.S. Amazon storefront had sales in its initial launch month in excess of $200,000 (or an annualized run-rate of $2.5 million). These sales were achieved with a soft launch and only 10 products (the product offering has since been expanded eight fold), and sales are...

DEXWireNews

Earnings were a blow out and growth prospects very compelling to investors, which resulted in a 15% jump in the stock price. We are on the watch for continuation today. Roth Capital maintained a buy rating with a $15 price target stating that “We are more encouraged by the use case of the platform continuing to expand, not only into additional verticals but also...

DEXWireNews

MR TRUMP turned this stock into a spin yesterday as it gained 300% on his tweet announcing that GM will be selling their Lordstown Plant to electric truck company Workhouse Group. Keep it on the watch for announcements and confirmations of contracts etc. Company Description Workhorse Group, Inc. engages in designing and build performance battery-electric...

DEXWireNews

Be on the watch-out for massive continuation today after great results yesterday. Already up 19% premarket. RESULTS TRANSCRIPT “In the first part of this year, we continued to make progress on our lead development program Gencaro, achieving an agreement with the FDA on our Special Protocol Assessment for the PRECISION-AF Phase 3 clinical trial evaluating Gencaro...

DEXWireNews

It has been a fantastic few weeks for investors in ADOM, having secured a massive contract recently, their upbeat earnings report was very well received. Jim Reynolds, CEO of ADOMANI, commented, ''We've made a lot of progress thus far in 2019. Backlog at March 31, 2019 was $12.9 million, a 50% increase over the December 31, 2018 backlog of $8.6 million. As of...